Lisa Desiderato

Lisa Desiderato currently serves as the Head of Marketing for US Oncology at Takeda since January 2024. Prior to this role, Lisa was with Bayer from April 2020 to January 2024, where positions included Vice President of US Sales and Marketing for Precision Medicine and Executive Director for US Oncology Precision Medicine. Lisa's experience with Pfizer spanned from 2009 to 2020, where responsibilities included leading the US Oncology Commercial Team, managing the Crisaborole global marketing strategy, and overseeing the Xeljanz Rheumatology and Healthcare Professional teams. Lisa holds a Ph.D. in Biomedical Science from the University of Technology Sydney and an MBA from AGSM at UNSW Business School.